Stefania Saragoni[au] - Search Results

Year	Number of Results
2002	1
2003	1
2004	3
2005	1
2010	1
2011	1
2012	2
2013	1
2014	3
2015	1
2016	1
2017	1
2018	2
2019	2
2020	2
2023	1
2024	3
2025	4
2026	0

1

RWE in oncologia: uso dei database per identificare i sottotipi molecolari del cancro mammario metastatico in Italia.

Perrone V, Cappuccilli M, Leogrande M, Saragoni S, Luciani AC, Barni S, Esposti LD. Perrone V, et al. Among authors: saragoni s. Glob Reg Health Technol Assess. 2025 Sep 5;12:198-204. doi: 10.33393/grhta.2025.3568. eCollection 2025 Jan-Dec. Glob Reg Health Technol Assess. 2025. PMID: 40919480 Free PMC article. Italian.

2

Evaluation of biochemical and economic outcomes in patients treated with PCSK9 inhibitors in a real clinical practice setting.

Dovizio M, Nugnes M, Iacolare B, Nappi C, Saragoni S, Andretta M, Barbieri A, Bartolini F, Chinellato G, Cillo M, Dell'orco S, Grego S, Lavalle A, Procacci C, Re D, Degli Esposti L. Dovizio M, et al. Among authors: saragoni s. Minerva Cardiol Angiol. 2025 Aug;73(4):422-431. doi: 10.23736/S2724-5683.24.06626-2. Epub 2025 Apr 28. Minerva Cardiol Angiol. 2025. PMID: 40292681

3

The Integrated Multidisciplinary Pathway for Large-Scale Management of Dyslipidemia in High-Risk Patients (ENNA) Project: Rationale and Project Design.

Agnello F, Russo C, Laterra G, Ingala S, Saragoni S, Giuffrida M, Greca PM, La Tona F, Rinaldi N, Gagliano I, Nappi C, Ghigi A, Cappuccilli M, Esposti LD, Scalia L, Cassarà E, Barbanti M. Agnello F, et al. Among authors: saragoni s. Am J Cardiol. 2025 Apr 1;240:71-75. doi: 10.1016/j.amjcard.2024.12.027. Epub 2024 Dec 26. Am J Cardiol. 2025. PMID: 39732311

4

Real World Evidence on Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer in Italy: Insights From 2017 to 2021 Data.

Perrone V, Leogrande M, Cappuccilli M, Saragoni S, Cinti Luciani A, Degli Esposti L. Perrone V, et al. Among authors: saragoni s. Clinicoecon Outcomes Res. 2025 Mar 6;17:147-155. doi: 10.2147/CEOR.S496606. eCollection 2025. Clinicoecon Outcomes Res. 2025. PMID: 40066280 Free PMC article.

5

Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy.

Angelucci E, Artoni A, Fianchi L, Dovizio M, Iacolare B, Saragoni S, Esposti LD. Angelucci E, et al. Among authors: saragoni s. J Clin Med. 2024 Feb 27;13(5):1342. doi: 10.3390/jcm13051342. J Clin Med. 2024. PMID: 38592185 Free PMC article.

6

Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting.

Degli Esposti L, Perrone V, Sangiorgi D, Saragoni S, Dovizio M, Caprioli F, Rizzello F, Daperno M, Armuzzi A. Degli Esposti L, et al. Among authors: saragoni s. Dig Liver Dis. 2024 Jan;56(1):29-34. doi: 10.1016/j.dld.2023.04.022. Epub 2023 May 3. Dig Liver Dis. 2024. PMID: 37147200

7

Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.

Petta S, Ting J, Saragoni S, Degli Esposti L, Shreay S, Petroni ML, Marchesini G; a LHUs group. Petta S, et al. Among authors: saragoni s. Nutr Metab Cardiovasc Dis. 2020 Jun 9;30(6):1014-1022. doi: 10.1016/j.numecd.2020.02.016. Epub 2020 Mar 5. Nutr Metab Cardiovasc Dis. 2020. PMID: 32423665

8

[Pharmaco-utilization and outcomes in patients treated with oral anticoagulants from 2014 to 2015: evidences from administrative databases of the Romagna Local Health Unit].

Degli Esposti L, Perrone V, Saragoni S, Buda S, Piovaccari G. Degli Esposti L, et al. Among authors: saragoni s. G Ital Cardiol (Rome). 2020 Jan;21(1):25-33. doi: 10.1714/3285.32587. G Ital Cardiol (Rome). 2020. PMID: 31960832 Italian.

9

Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study.

Esposti LD, Perrone V, Saragoni S, Blini V, Buda S, D'avella R, Gasperini G, Lena F, Fanelli F, Gazzi L, Giorgino F. Esposti LD, et al. Among authors: saragoni s. J Diabetes Res. 2019 Dec 30;2019:3174654. doi: 10.1155/2019/3174654. eCollection 2019. J Diabetes Res. 2019. PMID: 31976334 Free PMC article.

10

Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.

Degli Esposti L, Girardi A, Saragoni S, Sella S, Andretta M, Rossini M, Giannini S; on the behalf of the Study group. Degli Esposti L, et al. Among authors: saragoni s. Endocrine. 2019 May;64(2):367-377. doi: 10.1007/s12020-018-1824-9. Epub 2018 Dec 4. Endocrine. 2019. PMID: 30515678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year